Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 7, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT.

R Shouval1, O Bondi2, H Mishan2

  • 11] The Division of Hematology and Bone Marrow Transplantation and Internal Medicine "F" Department, The Chaim Sheba Medical Center, Tel HaShomer, Israel [2] 2013 Pinchas Borenstein Talpiot Medical Leadership Program, The Chaim Sheba Medical Center, Tel HaShomer, Israel.

Bone Marrow Transplantation
|October 8, 2013
PubMed
Summary

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Bone marrow transplantation·2026
Same author

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study.

Bone marrow transplantation·2021
Same author

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.

Bone marrow transplantation·2020
Same author

Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria).

Bone marrow transplantation·2020
Same author

Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2019

Hematopoietic stem cell transplantation (HSCT) data is growing complex. Machine learning (ML) and data mining (DM) offer advanced tools for outcome prediction and donor selection in HSCT research.

Area of Science:

  • Hematology
  • Biostatistics
  • Artificial Intelligence

Background:

  • Hematopoietic stem cell transplantation (HSCT) data is increasingly abundant and complex due to organized registries and biological data integration.
  • Conventional statistical methods face limitations in handling large datasets with multiple variables and samples common in HSCT.
  • Machine learning (ML) and data mining (DM) are emerging as powerful analytical approaches for complex data scenarios.

Purpose of the Study:

  • To introduce hematologists and stem cell transplanters to the concepts, applications, strengths, and limitations of ML and DM techniques.
  • To discuss current research utilizing ML and DM in the field of HSCT.
  • To encourage the adoption of ML and DM for improved prediction of transplantation outcomes and donor selection.

Main Methods:

Related Experiment Videos

Last Updated: May 7, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

  • Review of machine learning (ML) and data mining (DM) concepts and their relevance to clinical research.
  • Exploration of existing applications of ML and DM in hematopoietic stem cell transplantation (HSCT).
  • Discussion of the advantages and disadvantages of ML and DM compared to traditional statistical methods.

Main Results:

  • ML and DM techniques offer enhanced capabilities for analyzing complex HSCT datasets.
  • These methods can potentially improve the accuracy of outcome prediction models and risk scores.
  • Applications include optimizing donor selection and predicting transplantation success.

Conclusions:

  • Machine learning and data mining represent a significant advancement for HSCT data analysis.
  • Wider adoption of these techniques can lead to more precise predictions and better patient management.
  • Further research and implementation are encouraged to fully leverage ML and DM in HSCT.